CN Patent

CN103748085A — 杂环磺酰胺衍生物

Assigned to Novartis AG · Expires 2014-04-23 · 12y expired

What this patent protects

本发明涉及式(I)化合物和其药学上可接受的盐。所述化合物已经被证实为MEK抑制剂，并因此可用于治疗过度增殖性疾病如癌症和炎症。

USPTO Abstract

本发明涉及式(I)化合物和其药学上可接受的盐。所述化合物已经被证实为MEK抑制剂，并因此可用于治疗过度增殖性疾病如癌症和炎症。

Drugs covered by this patent

Patent Metadata

Patent number
CN103748085A
Jurisdiction
CN
Classification
—
Expires
2014-04-23
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.